Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,383,863
+$7,133,997 QoQ
Shares Held
21,997
+5.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#771
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $166,003,072 across 9 Drug Manufacturers - General names. LLY ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
282,635 | $36,318,597 | |
| 2 | JNJ |
Johnson & Johnson
|
113,733 | $28,884,770 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
21,997 | $26,383,863 | |
| 4 | AMGN |
Amgen Inc
|
63,607 | $23,033,366 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
369,878 | $21,312,370 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
138,734 | $17,527,653 | |
| 7 | ABBV |
AbbVie Inc.
|
42,182 | $10,614,678 | |
| 8 | PFE |
Pfizer Inc
|
61,912 | $1,490,840 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,383,863 | 21,997 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,249,866 | 20,929 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,188,940 | 18,786 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,655,118 | 16,586 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,368,159 | 17,149 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $14,311,368 | 17,328 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,757,812 | 17,821 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,874,046 | 16,789 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,498,263 | 21,536 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $17,090,225 | 21,968 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,563,382 | 23,268 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,627,790 | 21,648 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,246,275 | 21,848 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,704,401 | 31,170 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,560,768 | 15,200 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,762,298 | 14,728 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,719,641 | 8,388 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,917,537 | 10,188 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,814,129 | 10,188 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,603,933 | 11,270 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,634,449 | 15,835 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,107,750 | 16,635 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,950,777 | 11,554 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,840,355 | 19,189 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,223,181 | 19,632 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,888,150 | 20,820 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||